JP2004504379A5 - - Google Patents

Download PDF

Info

Publication number
JP2004504379A5
JP2004504379A5 JP2002514092A JP2002514092A JP2004504379A5 JP 2004504379 A5 JP2004504379 A5 JP 2004504379A5 JP 2002514092 A JP2002514092 A JP 2002514092A JP 2002514092 A JP2002514092 A JP 2002514092A JP 2004504379 A5 JP2004504379 A5 JP 2004504379A5
Authority
JP
Japan
Prior art keywords
pyrrolidine
carboxylic acid
mercapto
alkyl
methyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2002514092A
Other languages
English (en)
Japanese (ja)
Other versions
JP3983663B2 (ja
JP2004504379A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2001/007951 external-priority patent/WO2002008185A1/en
Publication of JP2004504379A publication Critical patent/JP2004504379A/ja
Publication of JP2004504379A5 publication Critical patent/JP2004504379A5/ja
Application granted granted Critical
Publication of JP3983663B2 publication Critical patent/JP3983663B2/ja
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

JP2002514092A 2000-07-19 2001-07-10 メタロプロテアーゼインヒビターとしてのピロリジン誘導体 Expired - Lifetime JP3983663B2 (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP00114949 2000-07-19
PCT/EP2001/007951 WO2002008185A1 (en) 2000-07-19 2001-07-10 Pyrrolidine derivatives as metalloprotease inhibitors

Publications (3)

Publication Number Publication Date
JP2004504379A JP2004504379A (ja) 2004-02-12
JP2004504379A5 true JP2004504379A5 (cg-RX-API-DMAC7.html) 2005-02-24
JP3983663B2 JP3983663B2 (ja) 2007-09-26

Family

ID=8169226

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2002514092A Expired - Lifetime JP3983663B2 (ja) 2000-07-19 2001-07-10 メタロプロテアーゼインヒビターとしてのピロリジン誘導体

Country Status (15)

Country Link
US (3) US20020040146A1 (cg-RX-API-DMAC7.html)
EP (1) EP1303486A1 (cg-RX-API-DMAC7.html)
JP (1) JP3983663B2 (cg-RX-API-DMAC7.html)
KR (1) KR100613196B1 (cg-RX-API-DMAC7.html)
CN (1) CN100406439C (cg-RX-API-DMAC7.html)
AR (1) AR037990A1 (cg-RX-API-DMAC7.html)
AU (2) AU2001278479B2 (cg-RX-API-DMAC7.html)
BR (1) BR0112655A (cg-RX-API-DMAC7.html)
CA (1) CA2415740A1 (cg-RX-API-DMAC7.html)
MX (1) MXPA03000368A (cg-RX-API-DMAC7.html)
PA (1) PA8522301A1 (cg-RX-API-DMAC7.html)
PE (1) PE20020333A1 (cg-RX-API-DMAC7.html)
UY (1) UY26846A1 (cg-RX-API-DMAC7.html)
WO (1) WO2002008185A1 (cg-RX-API-DMAC7.html)
ZA (1) ZA200300170B (cg-RX-API-DMAC7.html)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002008185A1 (en) * 2000-07-19 2002-01-31 F. Hoffmann-La Roche Ag Pyrrolidine derivatives as metalloprotease inhibitors
US7405234B2 (en) * 2002-05-17 2008-07-29 Bristol-Myers Squibb Company Bicyclic modulators of androgen receptor function
WO2004033422A2 (en) 2002-10-07 2004-04-22 The Regents Of The University Of California Modulation of anxiety through blockade of anandamide hydrolysis
US7388027B2 (en) * 2004-03-04 2008-06-17 Bristol-Myers Squibb Company Bicyclic compounds as modulators of androgen receptor function and method
CN101376656A (zh) * 2007-08-30 2009-03-04 山东轩竹医药科技有限公司 培南衍生物
EP2234608A2 (en) 2007-12-11 2010-10-06 Viamet Pharmaceuticals, Inc. Metalloenzyme inhibitors using metal binding moieties in combination with targeting moieties
WO2010028051A2 (en) * 2008-09-03 2010-03-11 Florida State University Research Foundation, Inc. Substituted heterocyclic mercaptosulfonamide metalloprotease inhibitors
BR112017028448A2 (pt) 2015-07-02 2018-08-28 Horizon Orphan Llc análogos de cisteamina resistentes a ado e usos dos mesmos
CN111630032B (zh) * 2018-01-17 2024-06-07 米加尔-加利里研究院有限公司 新型蛋氨酸代谢途径抑制剂
CN111825582B (zh) * 2020-08-12 2022-04-08 江西理工大学 一种以芳基磺酰氯为硫源合成β-硫代羰基化合物的方法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1281720C (en) * 1984-11-08 1991-03-19 Makoto Sunagawa Carbapenem compounds and production thereof
US4925838A (en) * 1988-03-18 1990-05-15 Fujisawa Pharmaceutical Company, Ltd. 3-pyrrolidinylthio-1-azabicyclo[3.2.0]-hept-2-ene-2-carboxylic acid compounds
US5317016A (en) * 1991-08-20 1994-05-31 Shionogi Seiyaku Kabushiki Kaisha Pyrrolidylthiocarbapenem derivative
GB9301276D0 (en) * 1993-01-22 1993-03-17 Fujisawa Pharmaceutical Co Bicyclic compounds and their preparation
CA2184101C (en) * 1994-02-25 2005-11-22 Susumu Nakagawa Carbapenem derivatives
HUP9902316A3 (en) * 1996-02-13 2001-12-28 Abbott Lab 4-(benzo-1,3-dioxolyl)-pyrrolidine-3-carboxylic acid derivatives as endothelin antagonists and pharmaceutical compositions containing them
BR9712792A (pt) * 1996-08-28 1999-12-14 Procter & Gamble Inibidores de metaloprotease bidentada.
ES2201318T3 (es) * 1996-08-28 2004-03-16 THE PROCTER & GAMBLE COMPANY Inhibidores de metaloproteasas de aminas ciclicas substituidas.
BR0112580A (pt) * 2000-07-19 2003-06-17 Hoffmann La Roche Compostos, composições farmacêuticas que contêm os mesmos, utilização desses compostos, processo para tratamento terapêutico e/ou profilático e processo para a preparação desses compostos
WO2002008185A1 (en) * 2000-07-19 2002-01-31 F. Hoffmann-La Roche Ag Pyrrolidine derivatives as metalloprotease inhibitors

Similar Documents

Publication Publication Date Title
KR101004224B1 (ko) 인 함유 화합물 및 이의 용도
TWI623528B (zh) 金屬酶抑制劑化合物、抑制金屬酶活性之方法、組合物、治療或預防植物疾病或病症之方法及其用途
EP3661560B1 (en) Combination of atr kinase inhibitors and pd-1/pd-l1 inhibitors
JP2004504297A5 (cg-RX-API-DMAC7.html)
CN109863140A (zh) 3-氧代-2,6-二苯基-2,3-二氢哒嗪-4-甲酰胺
JP2012519179A5 (cg-RX-API-DMAC7.html)
JP2004504379A5 (cg-RX-API-DMAC7.html)
RU2005135337A (ru) Производные хиназолина для лечения злокачественного новообразования
RU2011146872A (ru) Производные пролина в качестве ингибиторов катепсина
JP2005523248A (ja) ジペプチジルペプチダーゼivの阻害剤
CN102438990A (zh) 取代的2-乙酰胺基-5-芳基-1,2,4-三唑酮和它的用途
JP2004536066A5 (cg-RX-API-DMAC7.html)
JP2006525276A5 (cg-RX-API-DMAC7.html)
HUE034298T2 (en) Use of 4- (Pyrrolidin-1-yl) quinoline derivatives to kill clinically latent microorganisms
JP2010533131A5 (cg-RX-API-DMAC7.html)
JP2013519667A (ja) 新規抗真菌性トリアゾール誘導体
JP2006501306A5 (cg-RX-API-DMAC7.html)
EP3558960B1 (en) Carboxylic acid aromatic amides as antagonists of bradykinin b1 receptor
CN112638376B (zh) 取代的四氢环戊二烯并[c]吡咯、取代的二氢吡咯嗪、其类似物和其使用方法
CA2304647A1 (en) Method for preventing and treating hearing loss using sensorineurotophic compounds
WO2002096420A2 (en) Method for treating nerve injury caused by surgery
CA2643005A1 (en) Imidazole-5-carboxylic acid derivatives,the preparation method therefor and the uses thereof
TW200522951A (en) New methods
RU2007102274A (ru) Пиперазиндионы как антагонисты рецептора окситоцина
CA2784007C (en) Pyrrolidine derivatives